Investor AB Posts Negative 3Q Total Shareholder Return of 3%
By Dominic Chopping
STOCKHOLM--Investor AB on Thursday reported a negative total shareholder return of 3% in the third quarter of 2023, unchanged from last year's same period.
Investor's net asset value per share slipped to 216 Swedish kronor ($19.60) at the end of September from SEK220 at the end of June. On an adjusted basis, NAV per share stood at SEK248.
The company posted a net loss attributable to shareholders of SEK11.09 billion in the third quarter, from a profit of SEK8.37 billion a year earlier, following a sharp decline in the value of its investments.
"As a consequence of the uncertainties out there, it remains imperative for us and our companies to ensure high flexibility and the ability to react swiftly to rapid changes," Chief Executive Johan Forssell said.
"I believe that our companies are doing a good job balancing short-term efficiency focus with longterm initiatives."
Investor is the investment vehicle of Sweden's prominent Wallenberg family.
Write to Dominic Chopping at dominic.chopping@wsj.com
(END) Dow Jones Newswires
October 19, 2023 03:21 ET (07:21 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year